RT @neerajaiims: A must read “masterpiece” by @PauloBergerot ... @montypal on current IO landscape of advanced RCC and bladder cancer with…
RT @neerajaiims: A must read “masterpiece” by @PauloBergerot ... @montypal on current IO landscape of advanced RCC and bladder cancer with…
RT @neerajaiims: A must read “masterpiece” by @PauloBergerot ... @montypal on current IO landscape of advanced RCC and bladder cancer with…
RT @neerajaiims: A must read “masterpiece” by @PauloBergerot ... @montypal on current IO landscape of advanced RCC and bladder cancer with…
RT @neerajaiims: A must read “masterpiece” by @PauloBergerot ... @montypal on current IO landscape of advanced RCC and bladder cancer with…
RT @neerajaiims: A must read “masterpiece” by @PauloBergerot ... @montypal on current IO landscape of advanced RCC and bladder cancer with…
Great stuff $exel
A must read “masterpiece” by @PauloBergerot ... @montypal on current IO landscape of advanced RCC and bladder cancer with in-depth rationale for combining TKIs with checkpoint inhibitors with emphasis on cabozantinib. Published TODAY in MCT @AACR journal.